----item----
version: 1
id: {1E559AF5-29D9-4C2A-8063-66840519BCC4}
database: master
path: /sitecore/content/ScripIntelligence/Home/Articles/2015/07/01/Belgian pharma Mithra raises euro72m through IPO
parent: {28F237FF-EEF1-41C5-A15C-B67E96203F9A}
name: Belgian pharma Mithra raises euro72m through IPO
master: {00000000-0000-0000-0000-000000000000}
template: {11380B5D-3531-4570-B213-EFC5312266E4}
templatekey: Article

----version----
language: en
version: 1
revision: a259a169-9a9a-40db-82fe-96edbd462645

----field----
field: {2D750EFF-9058-4ABF-A7FF-57FFE5DA1E3C}
name: Title
key: title
content-length: 50

Belgian pharma Mithra raises &euro;72m through IPO
----field----
field: {F1D1DC93-63DF-4AFA-B60F-B3A3E9D36675}
name: Sub Title
key: sub title
content-length: 48

Belgian pharma Mithra raises euro72m through IPO
----field----
field: {446A339B-E1D9-4DE1-8B5E-DB7942EF1723}
name: Body
key: body
content-length: 1185

<p>Proving there is still investment promise for drug developers in the area of women's health, Belgium-based Mithra Pharmaceuticals has raised &euro;72.3m (approximately $80m) via an initial public offering on Euronext Brussels. </p><p>Mithra's IPO final price hit the upper end of the &euro;10.50 to &euro;12.50 range set initially. And gross profits from the financing could reach &euro;83.1m, assuming the exercise in full of the over-allotment option of up to 903,571 additional new shares.</p><p>Most of the money will be used to continue the clinical development of the estrogen steroid hormone Estetrol (E4) in the indications of contraception and menopause up to the end of Phase III.</p><p>Mithra's successful funding backs up comments made <a href="http://www.scripintelligence.com/business/Still-room-for-innovators-in-womens-health-says-Bayer-358304" target="_new">earlier this year</a> by Bayer Healthcare UK's chief, Dr Alexander Moscho, who told <i>Scrip</i> there was plenty of room for growth in the area of women's health despite an increase in generic players and a retreat by big pharma firms. </p><p>Mithra's initial market capitalization is &euro;366.5m. </p><p>
----field----
field: {5BA0578F-65B7-4C22-8233-1603D698D8A4}
name: Summary
key: summary
content-length: 234

<p>Proving there is still investment promise for drug developers in the area of women's health, Belgium-based Mithra Pharmaceuticals has raised &euro;72.3m (approximately $80m) via an initial public offering on Euronext Brussels. </p>
----field----
field: {8F4EE718-6FA0-42A5-85C4-6C8FE8B1FCD4}
name: Navigation Title
key: navigation title
content-length: 48

Belgian pharma Mithra raises euro72m through IPO
----field----
field: {7C4FC796-1311-4DAA-81AC-85EAA2C1C108}
name: Actual Publish Date
key: actual publish date
content-length: 15

20150701T163014
----field----
field: {BDF7C8E1-869E-49FF-B9F5-854B3081A45D}
name: Created Date
key: created date
content-length: 15

20150701T163014
----field----
field: {C926A72A-39DA-446D-B78C-2A650F820A73}
name: Modified Date
key: modified date
content-length: 15

20150701T163014
----field----
field: {1616FE67-7278-4169-948E-C29B00EC8781}
name: Article Number
key: article number
content-length: 8

SC029122
----field----
field: {31603F25-6D9C-4954-BCDE-342E1E184A30}
name: Meta Title Override
key: meta title override
content-length: 50

Belgian pharma Mithra raises &euro;72m through IPO
----field----
field: {5AD65E47-7554-4CE5-87B0-7FB65051C05A}
name: Authors
key: authors
content-length: 38

{090E9A04-9B4B-4986-8BAF-06A6B07B978D}
----field----
field: {0F6C8F42-01DC-4E05-B63E-AA25D8AA0E09}
name: Legacy Publication
key: legacy publication
content-length: 38

{0F9CCE10-91C1-4F31-832A-266F482A5DAF}
----field----
field: {5795FF15-0942-41FF-8A77-3B73185F5E1B}
name: Escenic ID
key: escenic id
content-length: 6

359117
----field----
field: {25BED78C-4957-4165-998A-CA1B52F67497}
name: __Created
key: __created
content-length: 16

20160209T042415Z
----field----
field: {5DD74568-4D4B-44C1-B513-0AF5F4CDA34F}
name: __Created by
key: __created by
content-length: 18

sitecore\Anonymous
----field----
field: {8CDC337E-A112-42FB-BBB4-4143751E123F}
name: __Revision
key: __revision
content-length: 36

a259a169-9a9a-40db-82fe-96edbd462645
----field----
field: {D9CF14B1-FA16-4BA6-9288-E8A174D4D522}
name: __Updated
key: __updated
content-length: 16

20160209T042415Z
----field----
field: {BADD9CF9-53E0-4D0C-BCC0-2D784C282F6A}
name: __Updated by
key: __updated by
content-length: 18

sitecore\Anonymous
